201 related articles for article (PubMed ID: 19151926)
1. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.
Kawaguchi T; Horie S; Bouchenaki N; Ohno-Matsui K; Mochizuki M; Herbort CP
Int Ophthalmol; 2010 Feb; 30(1):41-50. PubMed ID: 19151926
[TBL] [Abstract][Full Text] [Related]
2. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.
Knecht PB; Mantovani A; Herbort CP
Int Ophthalmol; 2013 Oct; 33(5):571-7. PubMed ID: 23277207
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
[TBL] [Abstract][Full Text] [Related]
5. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.
Bouchenaki N; Herbort CP
Ophthalmology; 2001 Jan; 108(1):54-64. PubMed ID: 11150265
[TBL] [Abstract][Full Text] [Related]
6. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
7. Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot retinochoroiditis and Vogt-Koyanagi-Harada disease.
Balci O; Jeannin B; Herbort CP
Int Ophthalmol; 2018 Apr; 38(2):527-539. PubMed ID: 28299496
[TBL] [Abstract][Full Text] [Related]
8. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
9. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients.
Miyanaga M; Kawaguchi T; Miyata K; Horie S; Mochizuki M; Herbort CP
Jpn J Ophthalmol; 2010 Sep; 54(5):377-82. PubMed ID: 21052896
[TBL] [Abstract][Full Text] [Related]
11. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
Bacsal K; Wen DS; Chee SP
Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
[TBL] [Abstract][Full Text] [Related]
12. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis.
Fabro F; Herbort CP
Klin Monbl Augenheilkd; 2018 Apr; 235(4):424-435. PubMed ID: 29669371
[TBL] [Abstract][Full Text] [Related]
13. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.
da Silva FT; Hirata CE; Sakata VM; Olivalves E; Preti R; Pimentel SL; Gomes A; Takahashi WY; Costa RA; Yamamoto JH
BMC Ophthalmol; 2012 Aug; 12():40. PubMed ID: 22889440
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease.
Oshima Y; Harino S; Hara Y; Tano Y
Am J Ophthalmol; 1996 Jul; 122(1):58-66. PubMed ID: 8659599
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
16. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
Chee SP; Jap A
Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
[TBL] [Abstract][Full Text] [Related]
17. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.
Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820
[TBL] [Abstract][Full Text] [Related]
18. Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: a pilot report.
Balci O; Gasc A; Jeannin B; Herbort CP
Int Ophthalmol; 2017 Jun; 37(3):737-748. PubMed ID: 27486023
[TBL] [Abstract][Full Text] [Related]
19. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
Jap A; Chee SP
Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
[TBL] [Abstract][Full Text] [Related]
20. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.
Takemoto Y; Namba K; Mizuuchi K; Iwata D; Uno T; Ohno S; Hirooka K; Hashimoto Y; Saito W; Sugiyama K; Ishida S
Acta Ophthalmol; 2016 Nov; 94(7):e629-e636. PubMed ID: 27079805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
